Retatrutide, developed by Soma Pharmaceuticals , is attracting check here increasing attention as a potential method for metabolic regulation. This unique compound merges the mechanism of a GLP-1 receptor agonist and a GIP receptor stimulant, designed to simply promote weight loss but also address underlying metabolic conditions . Preliminary human